Back to search
FDAFDA · Food and drugs·Recall number D-0639-2021

Phytonadione Tablets, 5 mg, 30-count ablets, Rx only, Manufactured for: Oceanside Pharmaceuticals, a division of Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807 USA, NDC 68682-170-30

Published June 30, 2021 · Recall initiated: June 8, 2021

Summary

FDA records drug Class III recall D-0639-2021, published June 30, 2021 and initiated June 8, 2021. Recalling firm: Bausch Health Companies, Inc.; Status: Terminated; Reported quantity: 37,797 bottles; Lot: Lot #:19D013P, Exp Date 07/2021; 20D099P, Exp Date 10/2022. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Bausch Health Companies, Inc.
Distributor
Nationwide within the United States
Lot
Lot #:19D013P, Exp Date 07/2021; 20D099P, Exp Date 10/2022
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Phytonadione Tablets, 5 mg, 30-count ablets, Rx only, Manufactured for: Oceanside Pharmaceuticals, a division of Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807 USA, NDC 68682-170-30 recalled?

Yes. FDA published recall D-0639-2021 on June 30, 2021. Reported hazard: Failed Impurities/Degradation Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter